Abstract
An investigation of cell-penetrating peptides (CPPs) by using combination of Artificial Neural Networks (ANN) and Principle Component Analysis (PCA) revealed that the penetration capability (penetrating/non-penetrating) of 101 examined peptides can be predicted with accuracy of 80%-100%. The inputs of the ANN are the main characteristics classifying the penetration. These molecular characteristics (descriptors) were calculated for each peptide and they provide bio-chemical insights for the criteria of penetration. Deeper analysis of the PCA results also showed clear clusterization of the peptides according to their molecular features.
Keywords: Artificial neural networks (ANN), Cell-penetrating peptides (CPP), QSAR, PCA
Current Computer-Aided Drug Design
Title: Prediction of Cell-Penetrating Peptides Using Artificial Neural Networks
Volume: 6 Issue: 2
Author(s): Dimitar A. Dobchev, Imre Mager, Indrek Tulp, Gunnar Karelson, Tarmo Tamm, Kaido Tamm, Jaak Janes, Ulo Langel and Mati Karelson
Affiliation:
Keywords: Artificial neural networks (ANN), Cell-penetrating peptides (CPP), QSAR, PCA
Abstract: An investigation of cell-penetrating peptides (CPPs) by using combination of Artificial Neural Networks (ANN) and Principle Component Analysis (PCA) revealed that the penetration capability (penetrating/non-penetrating) of 101 examined peptides can be predicted with accuracy of 80%-100%. The inputs of the ANN are the main characteristics classifying the penetration. These molecular characteristics (descriptors) were calculated for each peptide and they provide bio-chemical insights for the criteria of penetration. Deeper analysis of the PCA results also showed clear clusterization of the peptides according to their molecular features.
Export Options
About this article
Cite this article as:
A. Dobchev Dimitar, Mager Imre, Tulp Indrek, Karelson Gunnar, Tamm Tarmo, Tamm Kaido, Janes Jaak, Langel Ulo and Karelson Mati, Prediction of Cell-Penetrating Peptides Using Artificial Neural Networks, Current Computer-Aided Drug Design 2010; 6 (2) . https://dx.doi.org/10.2174/157340910791202478
DOI https://dx.doi.org/10.2174/157340910791202478 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cantharidin as an Antitumor Agent: A Retrospective Review
Current Medicinal Chemistry Exosome-Mediated Drug Delivery for Cell-Free Therapy of Osteoarthritis
Current Medicinal Chemistry Design of NAALADase Inhibitors A Novel Neuroprotective Strategy
Current Medicinal Chemistry Glycine Transporter 1 Inhibitors and Modulation of NMDA Receptor-Mediated Excitatory Neurotransmission
Current Drug Targets A Comparative Insight on the Newly Emerging Rifamycins: Rifametane, Rifalazil, TNP-2092 and TNP-2198
Current Medicinal Chemistry Interplay Between ACE2 and Angiotensin-(1-7) in the Regulation of Blood Pressure
Current Hypertension Reviews High Mobility Group Box Protein-1 in HIV-1 Infection: Connecting Microbial Translocation, Cell Death and Immune Activation
Current HIV Research Visfatin/PBEF and Atherosclerosis-Related Diseases
Current Vascular Pharmacology Synthesis and Investigating Hypoglycemic and Hypolipidemic Activities of Some Glibenclamide Analogues in Rats
Mini-Reviews in Medicinal Chemistry Point of Care Ultrasound in Coronavirus 2019: Helpful or Not?
Current Respiratory Medicine Reviews Low Molecular Weight Inhibitors of the Protease Anthrax Lethal Factor
Mini-Reviews in Medicinal Chemistry Identify Compounds' Target Against Alzheimer's Disease Based on In-Silico Approach
Current Alzheimer Research Perspectives for Novel Mixed Diruthenium-Organic Drugs as Metallopharmaceuticals in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Emergence and Re-emergence of Human Coronaviruses: Spike Protein as the Potential Molecular Switch and Pharmaceutical Target
Current Pharmaceutical Design The Recent Development of Tetrahydro-Quinoline/Isoquinoline Based Compounds as Anticancer Agents
Current Topics in Medicinal Chemistry Lactones: Generic Inhibitors of Enzymes?
Mini-Reviews in Medicinal Chemistry Thiazoles and Thiazolidinones as Antioxidants
Current Medicinal Chemistry Anti Cancer, Molecular Docking and Structure Activity Relationship Studies of Some Novel Synthetic Spiroindolo[3,2-b]Carbazoles as Predicted HER2 and BrK Kinase Inhibitors
Current Bioactive Compounds Inhibitors of the Proteolytic Activity of Urokinase Type Plasminogen Activator
Current Pharmaceutical Design Binding of CYP2C9 with Diverse Drugs and its Implications for Metabolic Mechanism
Medicinal Chemistry